All groups |
Able to walk 4 m independently with or without walking aids
Able to give informed consent
Willingness to wear the sensor setups during the study
Shoe size 36 European Union (EU) (3 UK) or above
Able to read and write in first language of the respective country
Montreal Cognitive Assessment>1555
Available for home /office visit during study period
|
Occurrence of any of the following 3 months prior to inclusion: myocardial infarction, hospitalisation for unstable angina, stroke, coronary artery bypass graft, percutaneous coronary intervention, implantation of a cardiac resynchronisation therapy device
Current medical condition that could interfere with the patient’s compliance
|
COPD |
≥45 years of age
Diagnosis of COPD (post-bronchodilator forced expiratory volume in the first second (FEV1) to forced vital capacity ratio <0.70)
Clinical stability, defined as at least 4 weeks without antibiotics and/or oral corticosteroids to treat either a moderate or severe exacerbation
Current or ex-smokers with a smoking history equivalent to at least 10 pack years (1 pack year=20 cigarettes smoked per day for 1 year)
|
Having undergone major lung surgery (eg, lung volume reduction, lung transplant)
Having a lung tumour
Primary respiratory diseases other than COPD (eg, asthma)
Impaired mobility related to non-COPD causes, as judged by the investigator
|
PD |
|
|
MS |
|
|
PFF |
|
|
CHF |
|
|
HA |
65+ years of age |
|